← FDA Drug Approvals (Drugs@FDA)
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2019-05-16
Drug application
- FDA Application #
ANDA212266- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
- Generic name
- CETIRIZINE HYDROCHLORIDE
- Active ingredients
- CETIRIZINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- QUAGEN
- Manufacturer
- QUAGEN PHARMACEUTICALS LLC
- First approval
- 2019-05-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown